Systemic Lupus Erythematosus drug launch
May 29, 2026
7 Promising Late-Stage SLE Drugs & New SLE Treatments Expected to Enter Therapeutic Domain
Systemic lupus erythematosus (SLE) is a chronic autoimmune condition that can affect multiple parts of the body. In 2025, it was estimated that around 512,000 individuals in the United States were living with SLE, as per DelveInsight analysis, with new treatments for SLE urgently needed as 40% of treated SLE patien...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
